Jeffrey Y C Wong
Overview
Explore the profile of Jeffrey Y C Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoeben B, Saldi S, Aristei C, Engellau J, Ocanto A, Hiniker S, et al.
Radiother Oncol
. 2025 Feb;
206:110822.
PMID: 39993603
As a component of myeloablative conditioning before allogeneic hematopoietic stem cell transplantation (HSCT), Total Body Irradiation (TBI) is employed in radiotherapy centers all over the world. In recent and coming...
2.
Akhavan D, Subham S, Jeppson J, Aguilar B, Wong R, Hibbard J, et al.
Cells
. 2024 Jul;
13(13.
PMID: 38994929
Standard-of-care treatment for Glioblastoma Multiforme (GBM) is comprised of surgery and adjuvant chemoradiation. Chimeric Antigen Receptor (CAR) T cell therapy has demonstrated disease-modifying activity in GBM and holds great promise....
3.
Parsons D, Lim T, Teruel J, Galavis P, Agostinelli S, Liang J, et al.
Clin Transl Radiat Oncol
. 2023 Sep;
43:100674.
PMID: 37753462
We compiled a sampling of the treatment techniques of intensity-modulated total body irradiation, total marrow irradiation and total marrow and lymphoid irradiation utilized by several centers across North America and...
4.
Ladbury C, Mei M, Kafaja S, Nall J, Han C, Dandapani S, et al.
Int J Radiat Oncol Biol Phys
. 2023 Mar;
116(5):1019-1024.
PMID: 36868524
No abstract available.
5.
Ladbury C, Han C, Liu A, Wong J
Front Oncol
. 2023 Jan;
12:1042652.
PMID: 36686805
Background: The aim of this study is to report historical treatment planning experience at our institution for patients receiving total marrow and lymphatic irradiation (TMLI) using volumetric modulated arc therapy...
6.
Ladbury C, Semwal H, Hong D, Yang D, Hao C, Han C, et al.
Front Oncol
. 2022 Nov;
12:1017355.
PMID: 36387179
Background: Total Marrow and Lymphoid Irradiation (TMLI) is a promising component of the preparative regimen for hematopoietic cell transplantation in patients with high-risk acute myeloid leukemia (AML) and acute lymphoid...
7.
Wong J, Liu A, Han C, Dandapani S, Schultheiss T, Palmer J, et al.
Front Oncol
. 2022 Oct;
12:1003908.
PMID: 36263219
Purpose: TMI utilizes IMRT to deliver organ sparing targeted radiotherapy in patients undergoing hematopoietic cell transplantation (HCT). TMI addresses an unmet need, specifically patients with refractory or relapsed (R/R) hematologic...
8.
Wong J, Yamauchi D, Adhikarla V, Simpson J, Frankel P, Fong Y, et al.
Cancer Biother Radiopharm
. 2022 Sep;
38(1):26-37.
PMID: 36154291
PET imaging using radiolabeled immunoconstructs shows promise in cancer detection and in assessing tumor response to therapies. The authors report the first-in-human pilot study evaluating M5A, a humanized anti-carcinoembryonic antigen...
9.
Han C, Liu A, Wong J
Front Oncol
. 2022 Aug;
12:946725.
PMID: 35957914
Purpose/objectives: The aim of this study is to report historical treatment planning experience at our institution for patients receiving total marrow and lymphatic irradiation (TMLI) as part of the conditioning...
10.
Abdelhamid A, Jiang L, Zuro D, Liu A, Madabushi S, Ghimire H, et al.
Front Oncol
. 2022 Aug;
12:941814.
PMID: 35924145
Total marrow irradiation (TMI) has significantly improved radiation conditioning for hematopoietic cell transplantation in hematologic diseases by reducing conditioning-induced toxicities and improving survival outcomes in relapsed/refractory patients. Recently, preclinical three-dimensional...